首頁 > 市場調查報告書 > 製藥

非專利藥糖尿病生物製劑生技仿製藥

市場調查報告書

商品編碼

2075800

胰島素增敏劑市場：按類型、適應症、給藥途徑、分銷管道和地區分類

Insulin Sensitizers Market, By Type of Insulin Sensitizers, By Indication, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，胰島素敏感性增強劑市場規模將達到 253.4 億美元，到 2033 年將達到 396.4 億美元。預計 2026 年至 2033 年的複合年成長率將達到 6.6%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	253.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.60%	2033年市場規模預測：	396.4億美元

胰島素增敏劑是一種能夠提高胰島素敏感性並降低血糖值的藥物。它們也稱為血糖正常化劑或血糖穩定劑，有助於在不使用胰島素的情況下將血糖值恢復到正常範圍。這些藥物透過提高肝臟、肌肉和脂肪細胞的胰島素敏感性來發揮作用。胰島素增敏劑有多種類型，包括二甲雙胍（Met）、PIOGLITAZONE（Pio）、胰島素增敏劑（TZDs）和肌醇。

市場動態

全球胰島素敏感性增強劑市場的成長主要受糖尿病（尤其是第2型糖尿病）盛行率上升的驅動。胰島素敏感性增強劑常用於治療第2型糖尿病，以提高胰島素敏感性並控制血糖值。肥胖會顯著增加第二型糖尿病和胰島素抗性的風險。鑑於全球肥胖盛行率不斷上升，有效的胰島素敏感性增強劑有助於控制胰島素抗性及相關代謝性疾病。持續的研發活動正在推出新型和改良的胰島素敏感性增強劑，這些創新化合物和製劑能夠提高胰島素敏感性增強藥物的療效和安全性。此外，世界各國政府正採取多項措施來對抗糖尿病。這些計劃和項目著重於普及糖尿病知識、早期發現糖尿病以及促進患者獲得必要且價格合理的治療，例如胰島素敏感性增強劑。

與其他藥物一樣，胰島素增敏劑也存在潛在的副作用，例如體重增加、體液儲存、骨折以及心臟衰竭風險增加。某些類型的胰島素增敏劑，例如胰島素增敏劑（TZDs），可能引發安全隱患，因此其使用受到限制，難以廣泛應用。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球胰島素敏感性增強劑市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
全球胰島素敏感性增強劑市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球胰島素敏感性增強劑市場中使用的各種策略矩陣來簡化決策過程。

市場動態
- 促進因素
  - 糖尿病盛行率上升
  - 全球肥胖流行
  - 藥物研發進展
  - 理想的政府政策
- 抑制因子
  - 不良反應和安全問題
  - 對特定患者群體療效的局限性
  - 監管挑戰和市場准入
- 機會
  - 新興經濟體
  - 個人化醫療
  - 聯合治療
  - 在非糖尿病領域的應用
影響分析
主要亮點
監管趨勢
產品上市及核准
PEST分析
波特的分析
併購情景

第4章全球胰島素增敏劑市場：按類型分類，2021-2033年

胰島素增敏劑藥物（TZDs）
雙胍類藥物
基於腸促胰素的療法
其他

第5章全球胰島素增敏劑市場：依適應症分類，2021-2033年

2型糖尿病
糖尿病前期
卵巢症候群（PCOS）

第6章全球胰島素增敏劑市場：依給藥途徑分類，2021-2033年

口服
注射藥物

第7章全球胰島素增敏劑市場：依通路分類，2021-2033年

醫院藥房
零售藥房
網路藥房

第8章全球胰島素增敏劑市場：按地區分類，2021-2033年

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東和非洲
- GCC
- 以色列
- 北非
- 中非
- 其他中東和非洲國家

第9章競爭情勢

Eli Lilly and Company
Novo Nordisk
Sanofi
Merck & Co.
Bristol Myers Squibb
AstraZeneca
Boehringer Ingelheim
Johnson & Johnson
Takeda Pharmaceutical

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI6069

Insulin Sensitizers Market is estimated to be valued at USD 25.34 Bn in 2026 and is expected to reach USD 39.64 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 25.34 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.60%	2033 Value Projection:	USD 39.64 Bn

Insulin sensitizers are medications that improve insulin sensitivity and reduce blood sugar levels. These are also known as blood sugar normalizing agents and euglycemics, and these help in returning blood glucose to the normal range without using insulin. These work by increasing liver, muscle and fat cells' sensitivity to insulin. There are several different types of insulin sensitizers including metformin (Met), pioglitazone (Pio), thiazolidinediones (TZDs), and inositols.

Market Dynamics

Global insulin sensitizers market growth is driven by increased prevalence of diabetes, especially type 2 diabetes. Insulin sensitizers are frequently used to increase insulin sensitivity and manage blood glucose levels in the treatment of type 2 diabetes. Type 2 diabetes and insulin resistance are both significantly increased by obesity. Effective insulin sensitizer helps in controlling insulin resistance and related metabolic diseases due to rising prevalence of obesity worldwide. The ongoing research and development activities have introduced new and enhanced insulin sensitizers that creates innovative compounds and formulation methods, and improves the efficacy and safety profiles of drugs that treat insulin sensitivity. Furthermore, the governments have taken several initiatives to combat diabetes. The plans and the programs focus on spreading knowledge about diabetes, early detection of diabetes and facilitating necessary and affordable treatments like insulin sensitizers.

Like any drugs, insulin sensitizers have potential side effects like weight gain, fluid retention, bone fractures, and an elevated risk of heart failure. Specific kinds of insulin sensitizers such as thiazolidinediones (TZDs) may create worries about its safety concern, thus, restricting their use and make them difficult to embrace widely.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global insulin sensitizers market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Eli Lilly and Company, Novo Nordisk, Sanofi, Merck & Co., Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Takeda Pharmaceutical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global insulin sensitizers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insulin sensitizers market

Insulin Sensitizers Market Detailed Segmentation:

By Type (Revenue, USD Bn, 2021 - 2033)
Thiazolidinediones (TZDs)
Biguanides
Incretin-based therapies
Others
By Indication (Revenue, USD Bn, 2021 - 2033)
Type 2 Diabetes
Prediabetes
Polycystic Ovary Syndrome (PCOS)
By Route of Administration (Revenue, USD Bn, 2021 - 2033)
Oral
Injectable
By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Eli Lilly and Company
Novo Nordisk
Sanofi
Merck & Co.
Bristol Myers Squibb
AstraZeneca
Boehringer Ingelheim
Johnson & Johnson
Takeda Pharmaceutical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Insulin Sensitizers
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing prevalence of diabetes
  - Growing global obesity epidemic
  - Advancements in drug development
  - Favorable government initiatives
- Restraints
  - Adverse effects and safety concerns
  - Limited efficacy in certain patient populations
  - Regulatory challenges and market access
- Opportunities
  - Emerging economies
  - Personalized medicine
  - Combination therapies
  - Non-diabetic applications
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Insulin Sensitizers Market, By Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Thiazolidinediones (TZDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Biguanides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Incretin-based therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Insulin Sensitizers Market, By Indication, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn )
Prediabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Polycystic Ovary Syndrome (PCOS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Insulin Sensitizers Market, By Route of Administration, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Insulin Sensitizers Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

8. Global Insulin Sensitizers Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Insulin Sensitizers, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - GCC
  - Israel
  - North Africa
  - Central Africa
  - Rest of Middle East & Africa

9. Competitive Landscape

Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views